PEIRETTI, ENRICO
 Distribuzione geografica
Continente #
EU - Europa 111.580
NA - Nord America 9.007
AS - Asia 3.897
SA - Sud America 789
Continente sconosciuto - Info sul continente non disponibili 380
AF - Africa 161
OC - Oceania 45
Totale 125.859
Nazione #
IT - Italia 109.273
US - Stati Uniti d'America 8.701
SG - Singapore 1.497
CN - Cina 1.152
BR - Brasile 610
SE - Svezia 562
UA - Ucraina 351
VN - Vietnam 331
DE - Germania 301
GB - Regno Unito 287
FI - Finlandia 196
FR - Francia 180
IN - India 175
CA - Canada 163
HK - Hong Kong 140
BD - Bangladesh 115
NL - Olanda 109
MX - Messico 56
KR - Corea 55
AR - Argentina 53
ES - Italia 48
ZA - Sudafrica 44
RU - Federazione Russa 42
AU - Australia 40
TR - Turchia 40
IQ - Iraq 39
PH - Filippine 39
ID - Indonesia 35
PK - Pakistan 35
PL - Polonia 32
CH - Svizzera 31
CL - Cile 30
AT - Austria 29
JP - Giappone 29
TW - Taiwan 28
SA - Arabia Saudita 24
BE - Belgio 23
CO - Colombia 23
EG - Egitto 23
EC - Ecuador 22
IR - Iran 22
VE - Venezuela 22
MY - Malesia 18
MA - Marocco 17
AE - Emirati Arabi Uniti 15
IE - Irlanda 14
JO - Giordania 14
UZ - Uzbekistan 14
GR - Grecia 13
JM - Giamaica 13
TN - Tunisia 13
AZ - Azerbaigian 12
CR - Costa Rica 11
IL - Israele 11
PY - Paraguay 11
ET - Etiopia 10
HR - Croazia 9
MU - Mauritius 9
DK - Danimarca 8
DO - Repubblica Dominicana 8
DZ - Algeria 8
HN - Honduras 8
HU - Ungheria 8
LT - Lituania 8
NO - Norvegia 8
NP - Nepal 8
OM - Oman 8
PE - Perù 8
SV - El Salvador 8
KZ - Kazakistan 7
LY - Libia 7
NG - Nigeria 7
PT - Portogallo 7
RO - Romania 7
CZ - Repubblica Ceca 6
GT - Guatemala 6
NI - Nicaragua 6
PR - Porto Rico 6
RS - Serbia 6
TT - Trinidad e Tobago 6
BO - Bolivia 5
KE - Kenya 5
AL - Albania 4
AM - Armenia 4
BN - Brunei Darussalam 4
GP - Guadalupe 4
KG - Kirghizistan 4
NZ - Nuova Zelanda 4
PA - Panama 4
SN - Senegal 4
TH - Thailandia 4
UY - Uruguay 4
CI - Costa d'Avorio 3
CW - ???statistics.table.value.countryCode.CW??? 3
KH - Cambogia 3
LB - Libano 3
LI - Liechtenstein 3
LK - Sri Lanka 3
SC - Seychelles 3
YE - Yemen 3
Totale 125.444
Città #
Cagliari 104.764
Uta 3.869
Ashburn 1.135
Singapore 793
Fairfield 604
San Jose 550
Woodbridge 437
Chandler 400
Dallas 384
Nyköping 356
Houston 343
Boardman 324
Wilmington 270
Seattle 267
Ann Arbor 237
Cambridge 227
Beijing 223
Council Bluffs 221
Jacksonville 182
New York 178
Los Angeles 153
Santa Clara 152
Hong Kong 120
Dearborn 116
Helsinki 112
Lauterbourg 104
Shanghai 104
The Dalles 96
Hefei 94
Ho Chi Minh City 94
Boston 74
Milan 72
São Paulo 71
Hanoi 69
Buffalo 61
Nanjing 61
Rome 54
Chicago 53
Seoul 53
Toronto 41
Orem 40
Columbus 37
San Diego 37
Redondo Beach 33
London 31
Munich 31
Phoenix 31
Dong Ket 26
Atlanta 25
Redwood City 25
Sassari 24
Shenyang 24
Nuremberg 23
Tokyo 23
Denver 22
Montreal 22
Selargius 22
Guangzhou 21
Princeton 21
Brooklyn 20
Chennai 20
Frankfurt am Main 20
Johannesburg 20
Nanchang 20
Warsaw 20
Hebei 19
Amsterdam 18
North Bergen 18
Tianjin 18
Washington 18
Haiphong 17
Manchester 17
Miami 17
Cedar Knolls 16
Jiaxing 16
Mumbai 16
Rio de Janeiro 16
Yverdon 16
Baghdad 15
Brussels 14
Changsha 14
Stockholm 14
Augusta 13
Curitiba 13
Poplar 13
San Francisco 13
Slough 13
Zhengzhou 13
Amman 12
Da Nang 12
Detroit 12
Guayaquil 12
Kingston 12
Mexico City 12
Mountain View 12
Shenzhen 12
Ardabil 11
Belo Horizonte 11
Madrid 11
Moscow 11
Totale 118.653
Nome #
null 3.998
Glucose-6-phosphate-dehydrogenase deficiency as a risk factor for pterygium 3.218
null 2.985
Abnormal lipid accumulation and cluster formation of naive peripheral blood mononuclear cells: a useful tool for early detection of central nervous system damage in elderly 2.899
Pterygium and glucose-6-phosphate dehydrogenase deficiency 2.880
OCT angiography characteristics in patients with chronic CSCR complicated with polypoidal choroidal vasculopathy 2.166
Fibroblasts isolated from human pterygia exhibit altered lipid metabolism characteristics 2.022
Comparison of inverted flap and subretinal aspiration technique in full-thickness macular hole surgery: a randomized controlled study 2.019
mRNA Level Alterations Of Protein Involved In Cholesterol Ester Metabolism In Pterygium Fibroblast 1.970
Modulation of cholesterol homeostasis by antiproliferative drugs in human pterygium fibroblasts 1.776
Influence of macular choroidal thickness on visual function in highly myopic eyes 1.771
Use of a new intra-ocular spectral domain optical coherence tomography in vitreoretinal surgery 1.767
Novel P.Asp304gly mutation in best1 gene associated with atypical best vitelliform macular dystrophy phenotype and high intrafamilial variability 1.756
Photodynamic Therapy with Verteporfin for Corneal Neovascularization 1.726
Iatrogenic retinal breaks in ultrahigh-speed 25-gauge vitrectomy: A prospective study of elective cases 1.716
Intravitreal bevacizumab as a treatment for choroidal neovascularisation secondary to myopia: 4-year study results. 1.701
Elective surgery system strengthening: development, measurement, and validation of the surgical preparedness index across 1632 hospitals in 119 countries 1.695
Choroidal neovascularization in caucasian patients with longstanding central serous chorioretinopathy 1.680
null 1.601
Optical coherence tomography angiography findings in fellow eyes of choroidal neovascularisation associated with central serous chorioretinopathy 1.565
Terapia Fotodinamica dello Pterigio con Verteporfina 1.562
Unilateral retinitis pigmentosa: A proposal of genetic pathogenic mechanisms 1.554
Infrared imaging of choroidal involvement in Leber's idiopathic stellate neuroretinitis 1.530
Bilateral noncalcified astrocytic hamartomas in retinitis pigmentosa: Multimodal imaging evaluation over 8 years of follow-up 1.528
HUMAN AMNIOTIC MEMBRANE TO CLOSE RECURRENT, HIGH MYOPIC MACULAR HOLES IN PATHOLOGIC MYOPIA WITH AXIAL LENGTH OF ≥30 mm 1.520
OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY CHARACTERISTICS OF POLYPOIDAL CHOROIDAL VASCULOPATHY SECONDARY TO CHRONIC CENTRAL SEROUS CHORIORETINOPATHY 1.517
Proliferative Activity and Cholesterol Ester Metabolism in Primary Culture of Human Pterygium Fibroblasts 1.516
Strategy for the management of diabetic macular edema: the European Vitreo-Retinal Society macular edema study 1.485
Current surgical treatment of age-related macular degeneration 1.477
Engineering erythrocytes for the modulation of drugs' and contrasting agents' pharmacokinetics and biodistribution 1.471
Analysis of Fundus Autofluorescence in Patients with Different Genotypes and Phenotypes of Retinitis Pigmentosa (RP) 1.456
Optical coherence tomography angiography findings in cystoid macular degeneration associated with central serous chorioretinopathy 1.439
Retinal pigment epithelium apertures as a late complication of longstanding serous pigment epithelium detachments in chronic central serous chorioretinopathy 1.421
An international collaborative evaluation of central serous chorioretinopathy: different therapeutic approaches and review of literature. The European Vitreoretinal Society central serous chorioretinopathy study 1.414
Antiproliferative drugs reduce pterygium fibroblast growth rate by modulating cholesterol homeostasis 1.402
Vision-Related Quality of Life in Patients with Diabetic Macular Edema Treated with Intravitreal Aflibercept: The AQUA Study 1.379
Correspondence 1.356
null 1.350
Reliable Therapeutic Modalities to Treat Age-Related Macular Degeneration 1.290
Efficacy and safety of combined vitrectomy with intravitreal dexamethasone implant for advanced stage epiretinal membrane 1.289
Negative correlation between retinal displacement and ganglion cell layer thickness changes in eyes with epiretinal membrane 1.247
Polypoidal choroidal vasculopathy in association with choroidal nevus 1.241
Observation of Erythrocyte Dynamics in the Retinal Capillaries and Choriocapillaris Using ICG-loaded Erythrocyte Ghost Cells. 1.219
Anti-vascular endothelial growth factor therapy versus photodynamic therapy in the treatment of choroidal neovascularization secondary to central serous chorioretinopathy 1.210
Primary vitreoretinal lymphoma masquerading as acute posterior multifocal placoid pigment epitheliopathy 1.209
Evaluation of the Choroid in Eyes With Retinitis Pigmentosa and Cystoid Macular Edema 1.197
Polypoidal choroidal vasculopathy associated with tilted disc syndrome 1.156
The nature and frequency of neovascular age-related macular degeneration. 1.098
Photodynamic therapy of pterygium with verteporfin: a preliminary report 1.090
Photodynamic therapy in human pterygium. A preliminar report 1.058
Discrepancy in current central serous chorioretinopathy classification 1.042
null 1.035
Photodynamic therapy of corneal neovascularization with verteporfin 1.021
Unfavorable effect of photodynamic therapy for late subretinal neovascularization with chorioretinal anastomoses associated with idiopathic multiple serous detachments of the retinal pigment epithelium 1.020
Cognitive Impairment and Age-Related Vision Disorders: Their Possible Relationship and the Evaluation of the Use of Aspirin and Statins in a 65 Years-and-Over Sardinian Population 1.012
Unfavorable effect of photodynamic therapy in a multiple detachment of pigment epithelium complicated by choroidal neovascularization 1.010
Comparison between a fundus camera and scanning laser ophthalmoscope in acquiring fluorescence emission in vitro. 975
En Face Choroidal Vascularity in Both Eyes of Patients with Unilateral Central Serous Chorioretinopathy 958
Amniotic membrane transplantation in the surgical management of symblepharon following toxic epidermal necrolysis 953
Pseudo-vitelliform macular detachment and cuticular drusen: Exclusion of 6 candidate genes 921
Rebound macular edema following bevacizumab (Avastin) therapy for retinal venous occlusive disease. 914
Simultaneous presentation of idiopathic macular and posterior full-thickness retinal holes successfully treated with inverted internal limiting membrane flap technique. 897
Outcomes after giant peripheral retinotomy and anterior flap retinectomy for rhegmatogenous retinal detachments with advanced proliferative vitreoretinopathy using small gauge vitrectomy. 879
null 851
Repopulation of the retinal pigment epithelium after pigment epithelial rip. 827
Treatments for Ocular Diseases in Pregnancy and Breastfeeding: A Narrative Review. 815
Photodynamic therapy with Verteporfin (Visudyne) for pterygium 789
Diagnosis of Age Related Macular Degeneration. 789
Erratum: Strategy for the Management of Diabetic Macular Edema: The European Vitreo-Retinal Society Macular Edema Study (BioMed Research International) 770
Acute central serous chorioretinopathy and fundus autofluorescence 765
Macular hole formation following thermal laser photocoagulation in a patient with choroidal neovascular membrane and age-related macular degeneration. 763
Optical Coherence tomography in a case of a double macular hole . 719
Hyperexpression of low-density lipoprotein receptors and hydroxy-methylglutaryl-coenzyme A-reductase in human pinguecula and primary Pterygium 710
Choroidal neovascularization in sorsby fundus dystrophy treated with photodynamic therapy and intravitreal triamcinolone acetonide 689
Choroidal vascularity map in unilateral central serous chorioretinopathy: A comparison with fellow and healthy eyes 689
Effect of the First Year of COVID-19 Pandemic on Ophthalmological Practice: A Multi-Centre Italian Study with a Focus on Medico-Legal Aspects 678
Evolving Treatment Paradigm in the Management of Diabetic Macular Edema in the Era of COVID-19 677
Short-term choroidal vascular changes after aflibercept therapy for neovascular age-related macular degeneration 666
Ocular Surface Changes Associated with Face Masks in Healthcare Personnel during COVID-19 Pandemic 653
Late Effect of Irradiation of Choroidal Circulation. 644
Oral-ocular trans infection of Epstein Barr virus. A possible new way of transmission by wearing masks in the SARS-CoV-2 era 627
null 620
Dosing Regimens of Intravitreal Aflibercept for Diabetic Macular Edema Beyond the First Year: VIOLET, a Prospective Randomized Trial 613
Influence of fellow eye on the diagnosis and classification of central serous chorioretinopathy 609
Unusual clinical manifestation of sclerochoroidal calcifications. 608
Multimodal Imaging Based Predictors for the Development of Choroidal Neovascularization in Patients with Central Serous Chorioretinopathy 573
Central serous chorioretinopathy imaging biomarkers 568
Non-neovascular age-related macular degeneration with subretinal fluid 561
Analysis of Fundus Autofluorescence in Patients With Different Genotypes and Phenotypes of Retinitis Pigmentosa (RP) 548
Interocular asymmetry in distribution of leaks in central serous chorioretinopathy 545
Photodynamic therapy as a treatment option for peripapillary pachychoroid syndrome: a pilot study 542
Outer retinal tubulations in central serous chorioretinopathy associated with choroidal neovascularisation 496
Age-related macular degeneration and cognitive impairment show similarities in changes of neutral lipids in peripheral blood mononuclear cells 495
Two-Port “Dry Vitrectomy” as a New Surgical Technique for Rhegmatogenous Retinal Detachment: Focus on Macula-on Results 482
Quantitative and Qualitative Assessments of Retinal Structure with Variable A-Scan Rate Spectralis OCT: Insights into IPL Multilaminarity 474
Correlation of sectoral choroidal vascularity with angiographic leakage in central serous chorioretinopathy 472
Choroidal Anatomic Alterations After Photodynamic Therapy for Chronic Central Serous Chorioretinopathy: A Multicenter Study 445
INVERTED INTERNAL LIMITING MEMBRANE FLAP TECHNIQUE for MACULAR HOLE SURGERY WITHOUT EXTRA MANIPULATION of the FLAP 444
Relationship between nerve fiber layer hemorrhages and outcomes in central retinal vein occlusion 424
No Changes in Keratometry Readings and Anterior Chamber Depth after XEN Gel Implantation in Patients with Glaucoma. 388
Totale 119.257
Categoria #
all - tutte 175.048
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 175.048


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224.321 0 0 0 0 621 444 361 329 463 540 804 759
2022/202311.689 737 1.409 1.079 992 825 1.102 714 1.222 925 787 1.382 515
2023/202412.400 589 394 355 621 1.233 1.913 2.196 796 508 845 1.473 1.477
2024/202522.136 5.114 5.357 3.587 2.326 1.397 1.392 1.283 304 375 310 277 414
2025/20268.461 611 471 1.242 829 776 612 935 398 581 893 509 604
2026/20272.253 241 374 459 1.034 145 0 0 0 0 0 0 0
Totale 125.859